With recent advancements in the self-collection of blood allowing trial participants to provide blood specimen for lab testing from the comfort of their home, Q2 Solutions’ Chuck Drucker recently shared insights about the impact this decentralized trial solution may have on the clinical lab team and what sponsors need to account for during trial design and planning.
Read Chuck’s insights and the full article recently posted in Today’s Clinical Lab.
